(Bloomberg) -- H. Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc. in a $2.6 billion deal that boosts its drug pipeline for serious brain...
Nearly everyone likes an underdog. They're the ones who don't get the respect they deserve but often deliver pleasant surprises.Three Motley Fool contributors think...